Skip to content
Preprint

PETA:Parameter-Efficient Test-Time Adaptation for Virtual Screening

Aug 2026 · 0 citations · 29 references
Computer Science

TL;DR

This work forms the specialization of pretrained virtual screening models to individual pockets as a test-time adaptation problem and proposes PETA, a parameter-efficient framework that directly adapts pretrained model at test time and outperforms both pretrained and fully retrained baselines while updating only the LayerNorm parameters.

Abstract

Accurately ranking active ligands for a target protein pocket from massive chemical libraries remains a central challenge in virtual screening. DrugCLIP and its recent extensions substantially accelerate this process by encoding protein pockets and molecules into a shared embedding space. Despite this progress, further performance improvements typically require retraining the entire model, incurring substantial computational overhead and making target-specific customization inefficient. In this work, we formulate the specialization of pretrained virtual screening models to individual pockets as a test-time adaptation problem and propose PETA, a parameter-efficient framework that directly adapts pretrained model at test time. Given a target pocket, PETA constructs pocket-specific negatives through molecular diffusion and chemical validity filtering, and further moves them toward the reference ligand retrieved from structural databases via embedding-space mixup to create more challenging ranking tasks. A ranking objective then places greater emphasis on suppressing high-scoring invalid candidates that could contaminate the top-ranked screening results, providing structured supervision for lightweight adaptation. Experiments across diverse benchmarks demonstrate that this lightweight, pocket-specific adaptation outperforms both pretrained and fully retrained baselines while updating only the LayerNorm parameters, which account for approximately $0.03\%$ of the full model.

View source

Similar papers

Review Open access Jul 2026

BoltzMol-1: Towards Reliable Virtual Screening for Fast and Cost-Effective Hit Discovery

This work establishes a practical framework for low-throughput, cost-constrained discovery campaigns capable of delivering chemically tractable binders with favorable property profiles, and introduces a suite of ADMET models for kinetic solubility, lipophilicity, and Caco-2 permeability to improve developability at the...

Noah Getz, Geoffrey Smith, Avene Colgan et al. · 0 citations
Aug 2026

Evaluating BioEmu-Generated Kinase Ensembles Reveals Structure Selection as the Virtual Screening Bottleneck.

It is shown that prospective structure selection, rather than structure generation, represents the primary bottleneck in ensemble-based VS, highlighting an urgent need for novel structural descriptors to identify high-performing conformations.

Jaeoh Shin, K. Joo, Jejoong Yoo · 1 citation
Jul 2026

Real-World Assessment of Machine-Learned Docking Using Bioassay-Derived Benchmarks

This work systematically evaluates the performance of a popular ML-based docking method, DiffDock-Pocket, on high-throughput screening (HTS) data sets derived from the PubChem BioAssay database, a premier source of bioactivity data.

Furyal Ahmed, M. Soellner, Charles L. Brooks · 0 citations
Open access Jul 2026

Prioritising search for virtual screening via preliminary interpretable low-feature likelihood-based rankings of drug-target activity measures.

This article proposes an offline/online method that Wisely selects a small number of easy to compute features of both the amino acid sequence of the proteins and the molecular structure of the ligands, and discretises their domains, which induces a low-dimensional finitisation of proteins' and ligands' chemical spaces.

Riccardo Curcio, Toni Mancini, Enrico Tronci · 0 citations
Jul 2026

Abstract A024: FastBindRank, a novel, scalable method for high-fidelity virtual screening of ultra-large chemical libraries idendtifies novel HDAC11 inhibitors

FastBindRank is presented, a distillation-based framework that transfers the predictive power of a high-accuracy structure-based model (Boltz-2) into a computationally efficient sequence-based surrogate and can identify functionally active novel compounds from ultra-large virtual screening.

J. Dai, Yueyue Wang, N. Shan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.